PRAXIS PRECISION MEDICINES, INC. Temporary Equity, Liquidation Preference
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Temporary Equity, Liquidation Preference of $232.23 million as of 2020-09-30, per its 10-Q filed 2020-11-23.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2021-03-17
- 2020-09-30: Temporary Equity, Liquidation Preference $232.23M.
- 2019-12-31: Temporary Equity, Liquidation Preference $121.12M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2020-09-30 | $232.23M 10-Q · filed 2020-11-23 |
| 2019-12-31 | $121.12M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |